Incyte Corporation (INCY) earnings
INCY earnings moved a median of +0.16% by the close. Quarterly and annual INCY reports and results, each read against the price at its own news timestamp. Back to the INCY overview →
16 measured INCY earnings events.
Where these INCY earnings landedvs 16 measured INCY earnings reactions
| Middle 50% of INCY earnings reactions | -1.24% to +1.85% |
|---|---|
| Median reaction (to close) | +0.16% |
| Measured reactions | 16 |
Point-in-time · zero look-ahead
Half of the 16 INCY earnings events with a measured close landed between -1.24% and +1.85%; 50% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q INCYTE CORP For: Jun 30 | SEC filing · Form 10-Q | -1.14% | -1.37% | |
| Incyte Reports Second Quarter 2026 Financial Results and Provides Business Updates | Press release | +2.67% | +9.19% | |
| Form 10-Q INCYTE CORP For: Mar 31 | SEC filing · Form 10-Q | +3.12% | +0.86% | |
| Incyte Reports First Quarter 2026 Financial Results and Provides Business Updates | Press release | +1.09% | +3.16% | |
| Form 10-K INCYTE CORP For: Dec 31 | SEC filing · Form 10-K | -0.33% | -0.13% | |
| Form 10-Q INCYTE CORP For: Sep 30 | SEC filing · Form 10-Q | +1.69% | -1.90% | |
| Incyte Reports Third Quarter 2025 Financial Results and Provides Business Updates | Press release | -0.38% | -0.53% | |
| Form 10-Q INCYTE CORP For: Jun 30 | SEC filing · Form 10-Q | -0.40% | -0.37% | |
| Form 10-Q INCYTE CORP For: Mar 31 | SEC filing · Form 10-Q | -1.90% | +2.81% | |
| Form 10-K INCYTE CORP For: Dec 31 | SEC filing · Form 10-K | +1.33% | -1.76% | |
| Form 10-Q INCYTE CORP For: Sep 30 | SEC filing · Form 10-Q | +0.26% | +0.45% | |
| Form 10-Q INCYTE CORP For: Jun 30 | SEC filing · Form 10-Q | -1.22% | -4.07% | |
| Form 10-Q INCYTE CORP For: Mar 31 | SEC filing · Form 10-Q | +1.05% | +2.06% | |
| Form 10-K/A INCYTE CORP For: Dec 31 | SEC filing · Form 10-K | +0.48% | +1.78% | |
| Form 10-K INCYTE CORP For: Dec 31 | SEC filing · Form 10-K | -0.17% | -1.20% | |
| Form 10-Q INCYTE CORP For: Sep 30 | SEC filing · Form 10-Q | -0.24% | +0.69% |
Keep exploring
More INCY: analyst actions → · SEC filings → · INCY overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Novan, Inc. (NOVN) | 634 | -0.02% | 45% |
| Zimmer Biomet Holdings, Inc. (ZBH) | 634 | +0.11% | 59% |
| BIOSPECIFICS TECHNOLOGIES (BSTC) | 632 | 0.00% | 43% |
| Danaher Corporation (DHR) | 632 | +0.04% | 52% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.